Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia.
Alonso-Solís A, Ochoa S, Grasa E, Rubinstein K, Caspi A, Farkas K, Unoka Z, Usall J, Huerta-Ramos E, Isohanni M, Seppälä J, Reixach E, Berdún J, Corripio I, Group MR. Alonso-Solís A, et al. Among authors: isohanni m. Int J Environ Res Public Health. 2020 Oct 16;17(20):7527. doi: 10.3390/ijerph17207527. Int J Environ Res Public Health. 2020. PMID: 33081208 Free PMC article.
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos E, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J; m-Resist group; Grasa EM. Alonso-Solís A, et al. Among authors: isohanni m. BMJ Open. 2018 Jul 16;8(7):e021346. doi: 10.1136/bmjopen-2017-021346. BMJ Open. 2018. PMID: 30012788 Free PMC article.
Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966.
Korpela H, Miettunen J, Rautio N, Isohanni M, Järvelin MR, Jääskeläinen E, Auvinen J, Keinänen-Kiukaanniemi S, Nordström T, Seppälä J. Korpela H, et al. Among authors: isohanni m. Eur Psychiatry. 2020 Feb 21;63(1):e24. doi: 10.1192/j.eurpsy.2020.25. Eur Psychiatry. 2020. PMID: 32146919 Free PMC article.
Predictors of response to pharmacological treatments in treatment-resistant schizophrenia - A systematic review and meta-analysis.
Seppälä A, Pylvänäinen J, Lehtiniemi H, Hirvonen N, Corripio I, Koponen H, Seppälä J, Ahmed A, Isohanni M, Miettunen J, Jääskeläinen E. Seppälä A, et al. Among authors: isohanni m. Schizophr Res. 2021 Oct;236:123-134. doi: 10.1016/j.schres.2021.08.005. Epub 2021 Sep 5. Schizophr Res. 2021. PMID: 34496316 Free article. Review.
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study.
Grasa E, Seppälä J, Alonso-Solis A, Haapea M, Isohanni M, Miettunen J, Caro Mendivelso J, Almazan C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Usall J, Ochoa S, van der Graaf S, Jewell C, Triantafillou A, Stevens M, Reixach E, Berdun J; m-RESIST group; Corripio I. Grasa E, et al. Among authors: isohanni m. JMIR Form Res. 2023 Jun 30;7:e46179. doi: 10.2196/46179. JMIR Form Res. 2023. PMID: 37389933 Free PMC article.
233 results